Europe Structural Heart Market Forecast to 2028

Europe Structural Heart Market Forecast to 2028 – Regional Analysis – by Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)

Send Enquiry
Item ID: BMIRE00028942 Category: Tags: , ,

$2,100$3,500

Description

The Europe structural heart market is expected to grow from US$ 3,213.80 million in 2022 to US$ 4,909.25 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Availability of Innovative Structural Heart Services Fuel Europe Structural Heart Market

The availability of technologically advanced products and treatment services allows surgeons, physicians, and other healthcare providers to offer superior services to their patients, which helps them maintain the optimum quality of life. The innovations are not limited to healthcare facilities, and they are extended to programs that are being designed for patients to get benefits out of treatment facilities. Heart diseases are complex, and the success of their intervention depends on innovations bringing treatment options that were deemed impossible earlier into reality. The heart disease treatment landscape—from structural inventions to surgical valve therapies—has experienced breakthrough innovations over the past few decades. Companies in the structural heart market offer a broad portfolio of solutions for different heart conditions, including vascular disease, irregular heartbeats, and heart valve diseases. Physicians can now manage arrhythmias by using remote monitoring devices to keep a tab on their patients, thereby treating an array of structural heart conditions.

The food and Drug Administration (FDA) have approved various therapies that are limited to the selected groups the patients. For instance, Premier Health, one of the providers of innovative structural heart services, offers alcohol septal ablation treatment for hypertrophic cardiomyopathy. The treatment mainly uses a catheter-based technology. The balloon valvuloplasty, uses a transcatheter approach for widening up stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers. CentraCare’s Heart & Vascular Center used EchoPixel’s True3D and HTG pre-planning software, which provides mixed reality capabilities that allow structural heart care teams to interact with a real-time holographic version of the patient’s anatomy without physically touching it or exposing it to contrast agents and radiations.

The innovative technologies and techniques of structural heart programs are specifically designed to provide quality care for the best results for patients and provides less complications and shorter recovery times with long-lasting advantages. Such technologies are likely to attract more patients suffering from the structural heart diseases and eventually the benefits of the services are likely to enhance the growth of the market in the forecasted period.

Europe Structural Heart Market Overview

The European structural heart market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the structural heart market. The European structural heart market is expected to witness significant growth during the forecast period due to factors such as significant growth in elderly population, rise in the incidence of CVDs, and launch of innovative products by market players in the region. Also, there has been an increase in the number of product approvals for treating heart disease in Europe. Moreover, market players have undertaken a number of initiatives to attract a larger customer base and sustain the competitive nature of the market. All these factors are fueling the market growth in the region.

Europe Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

Europe Structural Heart Market Segmentation

The Europe structural heart market is segmented int product, procedure, end user, and country.

Based on product, the Europe structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Europe structural heart market in 2022.

Based on procedure, the Europe structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Europe structural heart market in 2022.

Based on end user, the Europe structural heart market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals segment held the largest share of the Europe structural heart market in 2022.

Based on country, the Europe structural heart market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe structural heart market in 2022.

Abbott Laboratories; Medtronic Plc; Boston Scientific Corp; Artivion Inc; Edwards Lifesciences Corp; Lepu Medical Technology Beijing Co Ltd; Braile Biomedical Industry, Commerce and Representations; and Micro Interventional Devices Inc are some of the leading companies operating in the Europe structural heart market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 7.3% CAGR, the Europe Structural Heart Market is Speculated to be Worth US$ 4,909.25 million by 2028, says Business Market Insights

According to Business Market Insights research, the Europe structural heart market was valued at US$ 3,213.80 million in 2022 and is expected to reach US$ 4,909.25 million by 2028, registering a CAGR of 7.3% from 2022 to 2028. Availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs are the factors attributed to the Europe structural heart market expansion.

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death Europe. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The UK Factsheet January 2022, published by the British Heart Foundation (BHF), shows that ~7.6 million people with cardiovascular diseases live in the UK. According to the same source, ~4 million men and ~3.6 million women were diagnosed with heart and circulatory diseases in the country in 2021. Owing to the high incidence of cardiovascular disease, there is a high demand for treatment procedures such as angioplasty and cardiac surgery for survival, which creates opportunities for companies providing structural heart valves and annuloplasty rings, among other devices. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice. Therefore, the burgeoning number of cardiovascular disease cases and training programs on structural heart boost the structural heart market.

On the contrary, high cost of procedures systems hampers the Europe structural heart market.

Based on product, the Europe structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held 40.4% share of Europe structural heart market in 2022, amassing US$ 1,297.87 million. It is projected to garner US$ 2,010.28 million by 2028 to expand at 7.6% CAGR during 2022-2028.

Based on procedure, the Europe structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held 43.7% share of Europe structural heart market in 2022, amassing US$ 1,403.76 million. It is projected to garner US$ 2,203.68 million by 2028 to expand at 7.8% CAGR during 2022-2028.

Based on end user, the Europe structural heart market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals held 47.6% share of Europe structural heart market in 2022, amassing US$ 1,531.34 million. It is projected to garner US$ 2,394.13 million by 2028 to expand at 7.1% CAGR during 2022-2028.

Based on country, the Europe structural heart market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe structural heart market in 2022. It was assessed at US$ 959.32 million in 2022 and is likely to hit US$ 1,531.68 million by 2028, exhibiting a CAGR of 8.1% during the 2022-2028.

Key players operating in the Europe structural heart market are Abbott Laboratories; Medtronic Plc; Boston Scientific Corp; Artivion Inc; Edwards Lifesciences Corp; Lepu Medical Technology Beijing Co Ltd; Braile Biomedical Industry, Commerce and Representations; and Micro Interventional Devices Inc, among others.

During 2020-2023, various companies have adopted organic growth strategies in structural heart market. Some of the activities that have helped the companies promote their growth are launches, enhancements, expansion, relocation activities. Medtronic, Boston Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, Artinian, CORCYM, and Abbott Laboratories are among the companies that have been implementing organic strategies, which, in turn, have brought about various changes in the health economics and outcomes research services market.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Structural Heart Market – by Product
1.3.2 Europe Structural Heart Market – by Procedure
1.3.3 Europe Structural Heart Market – by End User
1.3.4 Europe Structural Heart Market – by Country
2. Europe Structural Heart Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Structural Heart Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Expert’s Opinion
5. Europe Structural Heart Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. Europe Structural Heart Market -Europe Analysis
6.1 Europe Structural Heart Market Revenue Forecast and Analysis
7. Europe Structural Heart Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 Europe Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Structural Heart Market – Revenue and Forecast to 2028 – by Procedure
8.1 Overview
8.2 Europe Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Structural Heart Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Europe Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Structural Heart Market – Revenue and Forecast to 2028 -Country Analysis
10.1 Overview
10.1.1 Europe Structural Heart Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.1.4 Germany: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.1.4.1 Germany: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.1.4.2 Germany: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.1.5 Germany: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.1.2 UK: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UK: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 UK: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.2.4 UK: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.2.4.1 UK: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.2.4.2 UK: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.2.5 UK: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.1.3 France: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 France: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.3.4 France: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.3.4.1 France: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.3.4.2 France: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.3.5 France: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.1.4 Italy: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.4.4 Italy: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.4.4.1 Italy: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.4.4.2 Italy: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.4.5 Italy: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.1.5 Spain: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.5.4 Spain: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.5.4.1 Spain: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.5.4.2 Spain: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.5.5 Spain: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.1.6 Rest of Europe: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Europe Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Europe Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.1.6.4.1 Rest of Europe: Europe Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.1.6.4.2 Rest of Europe: Europe Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Europe Structural Heart Market, by End User, 2019-2028 (US$ Million)
11. Europe Structural Heart Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lepu Medical Technology Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aran Biomedical Teoranta
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Corcym UK Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. France Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Europe Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Europe Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Recent Organic Growth Strategies in Europe Structural Heart Market
Table 32. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Structural Heart Market Segmentation
Figure 2. Europe Structural Heart Market, by Country
Figure 3. Europe Structural Heart Market Overview
Figure 4. Occluders Segment Held Largest Share of Product Segment in Europe Structural Heart Market
Figure 5. Europe: PEST Analysis
Figure 6. Europe Experts’ Opinion
Figure 7. Europe Structural Heart Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Structural Heart Market – Revenue Forecast and Analysis – 2019-2028
Figure 9. Europe Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
Figure 10. Occluders: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Annuloplasty Rings: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Heart Valve Balloons: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
Figure 15. Heart Valve Stenosis: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Heart Valve Regurgitation: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Left Atrial Appendage Closure: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
Figure 19. Hospitals: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Cardiac Centers: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Structural Heart Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. Europe Structural Heart Market, by Country, 2021 & 2028 (%)
Figure 24. Germany: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. UK: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. France: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Italy: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Spain: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Europe: Europe Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Europe Structural Heart Market

– Abbott Laboratories
– Medtronic Plc
– Boston Scientific Corp
– Edwards Lifesciences Corp
– Lepu Medical Technology Beijing Co Ltd
– Aran Biomedical Teoranta
– Corcym UK Ltd

Reviews

There are no reviews yet.

Be the first to review “Europe Structural Heart Market Forecast to 2028”